11/26
02:16 pm
rvty
Revvity (NYSE:RVTY) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Revvity (NYSE:RVTY) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
11/20
01:38 pm
rvty
Revvity (NYSE:RVTY) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Revvity (NYSE:RVTY) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
11/10
07:45 am
rvty
Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities
Low
Report
Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities
10/28
08:21 am
rvty
Revvity (NYSE:RVTY) had its price target raised by analysts at Robert W. Baird from $122.00 to $123.00. They now have an "outperform" rating on the stock.
Low
Report
Revvity (NYSE:RVTY) had its price target raised by analysts at Robert W. Baird from $122.00 to $123.00. They now have an "outperform" rating on the stock.
10/28
08:00 am
rvty
Revvity to Present at Upcoming Investor Conferences
Low
Report
Revvity to Present at Upcoming Investor Conferences
10/28
07:02 am
rvty
Revvity (NYSE:RVTY) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
Revvity (NYSE:RVTY) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
10/27
03:04 pm
rvty
Revvity (NYSE:RVTY) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Low
Report
Revvity (NYSE:RVTY) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
10/27
06:00 am
rvty
Revvity Announces Financial Results for the Third Quarter of 2025
Low
Report
Revvity Announces Financial Results for the Third Quarter of 2025
10/24
10:11 am
rvty
Revvity (NYSE:RVTY) was given a new $122.00 price target on by analysts at Robert W. Baird.
Low
Report
Revvity (NYSE:RVTY) was given a new $122.00 price target on by analysts at Robert W. Baird.
10/23
04:05 pm
rvty
Revvity Board Declares Quarterly Dividend
Low
Report
Revvity Board Declares Quarterly Dividend
10/15
08:04 pm
rvty
Revvity (NYSE:RVTY) is now covered by analysts at Guggenheim. They set a "neutral" rating on the stock.
Low
Report
Revvity (NYSE:RVTY) is now covered by analysts at Guggenheim. They set a "neutral" rating on the stock.
10/14
08:00 am
rvty
Revvity Showcases Progress with Purpose in 2025 Impact Report
Low
Report
Revvity Showcases Progress with Purpose in 2025 Impact Report
10/7
02:42 pm
rvty
Revvity (NYSE:RVTY) had its price target lowered by analysts at Evercore ISI from $108.00 to $106.00. They now have an "outperform" rating on the stock.
Low
Report
Revvity (NYSE:RVTY) had its price target lowered by analysts at Evercore ISI from $108.00 to $106.00. They now have an "outperform" rating on the stock.
10/6
08:00 am
rvty
Revvity to Hold Earnings Call on Monday, October 27, 2025
Low
Report
Revvity to Hold Earnings Call on Monday, October 27, 2025
10/3
01:19 pm
rvty
Metagenomics Market Size Booms at 13.55% CAGR, Projects to Climb USD 8.39 Billion by 2034 [Yahoo! Finance]
Low
Report
Metagenomics Market Size Booms at 13.55% CAGR, Projects to Climb USD 8.39 Billion by 2034 [Yahoo! Finance]
10/2
08:01 am
rvty
Revvity (NYSE:RVTY) was given a new $100.00 price target on by analysts at Barclays PLC.
Low
Report
Revvity (NYSE:RVTY) was given a new $100.00 price target on by analysts at Barclays PLC.
10/2
08:00 am
rvty
Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes
Low
Report
Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes
9/29
08:25 am
rvty
Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis [Yahoo! Finance]
Low
Report
Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis [Yahoo! Finance]
9/29
08:00 am
rvty
Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis
Low
Report
Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis
9/22
02:53 pm
rvty
Revvity (NYSE:RVTY) had its price target lowered by analysts at Bank of America Corporation from $110.00 to $99.00. They now have a "buy" rating on the stock.
Low
Report
Revvity (NYSE:RVTY) had its price target lowered by analysts at Bank of America Corporation from $110.00 to $99.00. They now have a "buy" rating on the stock.
9/22
11:30 am
rvty
Lab Automation Market is Projected To Reach US$8.71 Billion By 2031 at CAGR of 6.3% | The Insight Partners
Low
Report
Lab Automation Market is Projected To Reach US$8.71 Billion By 2031 at CAGR of 6.3% | The Insight Partners
9/22
11:30 am
rvty
Lab Automation Market is Projected To Reach US$8.71 Billion By 2031 at CAGR of 6.3% | The Insight Partners
Low
Report
Lab Automation Market is Projected To Reach US$8.71 Billion By 2031 at CAGR of 6.3% | The Insight Partners
9/22
08:00 am
rvty
Revvity and Profluent Collaborate to Launch AI-Enhanced Adenine Deaminase Pin-point Base Editing Systems
Low
Report
Revvity and Profluent Collaborate to Launch AI-Enhanced Adenine Deaminase Pin-point Base Editing Systems
9/10
05:08 am
rvty
Revvity, Inc. (RVTY) Launches its New In Vivo Imaging Center of Excellence [Yahoo! Finance]
Low
Report
Revvity, Inc. (RVTY) Launches its New In Vivo Imaging Center of Excellence [Yahoo! Finance]